Related Experiment Videos
Infection caused by vancomycin-resistant Streptococcus sanguis II.
Antimicrobial Agents and Chemotherapy
|April 1, 1984
Summary
Vancomycin resistance in Streptococcus sanguis II bacteremia is rare but highlights treatment limitations. All Gram-positive bacteria from sterile sites require vancomycin susceptibility testing.
Area of Science:
- * Infectious Diseases
- * Microbiology
- * Antimicrobial Resistance
Background:
- * Vancomycin is a critical antibiotic for treating serious Gram-positive bacterial infections.
- * Viridans group Streptococcus species are common causes of bacteremia, particularly in immunocompromised patients.
Observation:
- * A case of bacteremia caused by vancomycin-resistant Streptococcus sanguis II is reported.
- * This isolate demonstrated resistance to vancomycin, a concerning finding for this typically susceptible species.
Findings:
- * The presence of vancomycin resistance in Streptococcus sanguis II challenges the reliability of vancomycin for all viridans group Streptococcus infections.
- * This case underscores the emergence of antimicrobial resistance in previously susceptible pathogens.
Implications:
- * Routine vancomycin susceptibility testing is recommended for all Gram-positive isolates from blood and sterile body fluids.
- * Clinicians should consider alternative treatment options for infections caused by viridans group Streptococcus species, especially in high-risk patients.
- * This finding necessitates ongoing surveillance for vancomycin resistance in clinically significant bacteria.